InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: dr_lowenstein post# 284298

Tuesday, 02/20/2018 10:47:37 PM

Tuesday, February 20, 2018 10:47:37 PM

Post# of 402169

none of the links support anything about embeda instability





https://www.reuters.com/article/pfizer-recall/pfizer-recalls-pain-drug-acquired-in-king-deal-idUSN1618366120110316




MARKET NEWSMARCH 16, 2011

Pfizer recalls pain drug acquired in King deal

Ransdell Pierson


Embeda, which has annual sales of less than $70 million, was recalled in the United States because of a stability defect found in the extended-release product during routine testing, according to a notice posted Wednesday on the drug’s website, Embeda.com.

The drug contains pellets of morphine that surround naltrexone, a chemical which blocks opiate effects if the product is crushed or chewed -- thereby deterring misuse or abuse. The naltrexone component was shown to have degraded to unacceptable degrees in samples of Embeda that were tested, Pfizer said. The problem is unlikely to pose a safety risk and patients can continue taking the drug as prescribed, the drugmaker said.

Embeda, approved by U.S. regulators in August 2009, was recalled three times last year due to other formulation problems, all relating to how it dissolves, Pfizer spokeswoman Joan Campion said.








Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News